On Tuesday, stocks extended their rally from the previous session.

| TUE, DEC 07, 2021 | | | DOW | NAME | LAST | CHG | %CHG | AAPL | 171.18 | +5.86 | +3.54% | INTC | 52.57 | +1.58 | +3.10% | MSFT | 334.92 | +8.73 | +2.68% | |
| S&P 500 | NAME | LAST | CHG | %CHG | AAPL | 171.18 | +5.86 | +3.54% | INTC | 52.57 | +1.58 | +3.10% | F | 19.96 | +0.74 | +3.85% | | | NASDAQ | NAME | LAST | CHG | %CHG | AAPL | 171.18 | +5.86 | +3.54% | INTC | 52.57 | +1.58 | +3.10% | NVDA | 324.27 | +23.90 | +7.96% | | | | On Tuesday, stocks extended their rally from the previous session, with the Nasdaq Composite notching its best day since March 9. The tech-heavy index led the market rebound, after lagging the other major averages in the prior session. It jumped 3% Tuesday as investors bought the dip in tech stocks and other risky names. The Dow Jones Industrial Average added 1.4%, and the S&P 500 rose 2%. Cloud and chip stocks were among the biggest gainers, followed by energy names. Okta and CrowdStrike rose 5.7% and 4.9%, respectively. Intel leapt 3.1% on news that it plans to take its self-driving car unit public next year. In energy, Diamondback and Devon Energy each added more than 6%. Big Tech stocks Microsoft, Amazon and Alphabet rose, too. Apple gained 3.5% after Morgan Stanley increased its price target on the stock to $200. Shares of the iPhone maker closed at $171.18 on Tuesday and notched an all-time high during the session. Elsewhere, investor confidence got a boost from British drugmaker GlaxoSmithKline, which said its antibody treatment is effective against the omicron variant, based on new data. Its shares added 1.3%. |
Tidak ada komentar:
Posting Komentar